• Saturday,September 21,2024
ururembotoursandtravel.com
X

GSK on X: We have submitted the circular and prospectus in relation to our proposed demerger of our consumer healthcare business @Haleon_health to the FCA for approval and expect to publish the

$ 13.00

4.9 (415) In stock

Share

Update: Proposed demerger of the Consumer Healthcare business from

GSK to boost growth with Consumer Healthcare business spin-off

Haleon CMD to demerger archive

GSK Consumer Healthcare to be renamed Haleon after demerger

Glaxo/Pfizer Consumer Healthcare Joint Venture Spin-off Notes

Investors

Haleon CMD to demerger archive

Haleon CMD to demerger archive

Investors

Update: Proposed demerger of the Consumer Healthcare business from

Investors